John Byrd
, Professor and Chair, Department of Internal Medicine · University of Cincinnati Medical Center Inc.
Credentials: · · · · ·
History
PresentInternal Medicine Department · University of Cincinnati Medical Center Inc.
- Present
UPMC Hillman Cancer Center · UPMC Medical Education
- 1994–1995
Hematology
- 1991–1994
Internal Medicine
1987–1991
Research
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Nature · 2000 · 6,794 citations
The Lancet Oncology · 2009 · 2,176 citations
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2013 · First of 21 authors · Corresponding · 1,914 citations
- MG
145 papers
132 papers · 8 as a fellow
84 papers
- JJ
76 papers
74 papers · 4 as a fellow
68 papers
- LA
61 papers
59 papers
Grants
- 2025–2030
Pharmacodynamically Directed Targeted Therapy for Leukemia
National Cancer Institute · R01
Contact PI · $1.4M · University of Pittsburgh at Pittsburgh
- 1997–2027
National Cancer Institute · P30
Contact PI · $12.2M · University of Pittsburgh at Pittsburgh
- 2014–2027
NCI ETCTN Pittsburgh Cancer Consortium (PCC)
National Cancer Institute · UM1
PI · $1.4M · University of Pittsburgh at Pittsburgh
- 2019–2026
ITSC for Leukemia: Novel Molecular Strategies for NCTN "Individualized" Therapies
National Cancer Institute · UG1
Contact PI · $3.8M · University of Cincinnati
Clinical trials
- 2010–2013
Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
Principal investigator · Completed · Phase 1
Xencor, Inc.
- 2005–2009
Principal investigator · Completed · Phase 2
Ohio State University Comprehensive Cancer Center
- 2005–2012
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
- 2004
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)